Shares ALUMIS INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 24th, 2024 • Alumis Inc. • Pharmaceutical preparations • New York
Alumis Inc., a Delaware corporation (the “Company”), proposes, subject to terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom Morgan Stanley & Co. LLC, Leerink Partners LLC, Cantor Fitzgerald & Co. and Guggenheim Securities, LLC are acting as representatives (the “Representatives”), [_________] shares of its common stock, par value $0.0001 per share (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters not more than an additional [_________] shares of its common stock, par value $0.0001 per share (the “Additional Shares”), if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The
ALUMIS INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • June 24th, 2024 • Alumis Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is dated as of __________, and is between Alumis Inc., a Delaware corporation (together with its subsidiaries, the “Company”), and __________ (“Indemnitee”).
